Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23494214 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years
Condition: Infections, Meningococcal
Interventions: Biological: Meningococcal vaccine GSK 134612;   Biological: MencevaxACWY TM

Indicates status has not been verified in more than two years